• The document is a transcript of Neogen Chemicals Limited's Q4 FY26 Earnings Conference Call held on May 18, 2026, at 4:30 p.m. IST.
  • The call was moderated by Mr. Nishid Solanki from CDR India. Senior management participants included Mr. Anurag Surana (Non-Executive Chairman), Dr. Harin Kanani (Managing Director), and Mr. Gopikrishnan Sarathy (Chief Financial Officer).
  • The stated purpose of the call was to discuss the company's fourth quarter and full year FY26 financial results and provide strategic updates, particularly on the battery materials business and expansion projects.
  • The meeting was held after the earnings announcement, as it references the Q4 FY26 earnings presentation that had been shared and uploaded on stock exchange websites.
  • The transcript was submitted to the BSE and NSE on May 25, 2026, and is also available on the company's website at https://neogenchem.com/financial-performance/.
  • A standard disclaimer was provided at the beginning of the call, noting that certain statements may be forward-looking and actual results could vary.

Financial Highlights & Guidance (as disclosed during the call)

Q4 FY26 Performance (Consolidated):

  • Revenue: INR 247 crore (up 22% YoY)
  • EBITDA: INR 44 crore (up 21% YoY)
  • EBITDA Margin: 17.8%
  • Profit After Tax (PAT): INR 11 crore

Segment-wise Revenue (Q4 FY26):

  • Organic Chemicals: INR 194 crore (up 7% YoY)
  • Inorganic Chemicals: INR 53 crore (up 145% YoY)
  • Neogen Ionics (Battery Materials): INR 13 crore (for Q4); INR 36 crore (for full year FY26)

Full Year FY26 Performance (Consolidated):

  • Revenue: INR 862 crore (up 11% YoY)
  • EBITDA: INR 137 crore
  • PAT: INR 29 crore

FY27 Guidance:

  • Standalone Revenue (non-battery business): INR 875 crore to INR 950 crore
  • Neogen Ionics Revenue (battery materials): Over INR 300 crore (majority expected in H2 FY27)

Operational & Strategic Updates:

  • Dahej Replacement Facility: Construction progressing rapidly; commissioning on track for June 2026.
  • Insurance Claims: Received a recent tranche of INR 60 crore in February 2026; total cumulative on-account claims received stand at INR 140 crore plus salvage realization of INR 7 crore; net claim receivable is INR 203 crore.
  • Battery Chemicals Business (Neogen Ionics):
  • Pakhajan greenfield site: Commercial manufacturing for electrolyte targeted for H1 FY27; electrolyte salts expected in H2 FY27.
  • Project achieved mechanical assembly completion and transitioned to trial run phase.
  • Revised project timelines and capital outlays: Dahej Phase 1 budgeted at INR 428 crore (completion by February 2027); Pakhajan Phase 2 revised cost at INR 1,367 crore (expected completion by March 2027).
  • Strategic partnership with Japan's Morita: Equity contribution of $20 million expected in H1 FY27.
  • Balance Sheet: Consolidated total debt reached INR 1,330 crore in FY26; net debt at INR 1,295 crore.
  • Dividend: Board recommended a final dividend of INR 1 per equity share for FY26.

Additional Notes Section

  • The document is an edited transcript of the earnings conference call, with a disclaimer noting that it may contain transcription/editing errors, and the company takes no responsibility for such errors.
  • The transcript itself does not contain attached presentations or financial decks; it is a verbatim record of the conference call proceedings.
  • The summary includes all financial figures, project updates, and guidance explicitly disclosed during the call.